But this is really important, and I really do appreciate your holding this hearing, Mr. Chairman. This is critical.
We all know that traumatic brain injury can have devastating, lifelong consequences for our servicemembers and our veter...
No? And why not?
I support strengthening those disclosure rules. I have written legislative language to do it.
We have to find ways to bring down the cost of prescription drugs and the National Academies recommends that the Federal...
It is legal, but if drug companies have influence over which drugs these charities help patients buy, then under current...
Are you still committed to prioritizing basic and applied research? Will this commitment be reflected in the fiscal year...
Cures also fell short in a really big way, and that's on funding.
Frankly, it didn't even come close, and that's why today we're reintroducing the National Biomedical Research Act, which...
I led Democrats on this Committee in calling for an extra $50 billion for the NIH and the FDA.
I am worried that splitting oversight of R&D from acquisition is going to make this problem even worse.